Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for December 13

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 13th:

American Equity Investment Life Holding Company (AEL - Free Report) : This provider of life insurance products and services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 39.1% over the last 60 days.

American Equity Investment Life has a price-to-earnings ratio (P/E) of 5.26, compared with 11.20 for the industry. The company possesses a Value Score of A.

Navios Maritime Partners L.P. (NMM - Free Report) : This company that owns and operates dry cargo vessels has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 29.5% over the last 60 days.

Navios Maritime Partners has a price-to-earnings ratio (P/E) of 6.72, compared with 20.50 for the industry. The company possesses a Value Score of A.

Bausch Health Companies Inc. (BHC - Free Report) : This company that develops, manufactures, and markets a range of pharmaceutical, medical device in the therapeutic areas of eye health, gastroenterology, and dermatology has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.1% over the last 60 days.

Bausch Health has a price-to-earnings ratio (P/E) of 6.73, compared with 16.00 for the industry. The company possesses a Value Score of A.

Office Depot, Inc. (ODP - Free Report) : This company that provides business services and supplies, products, and technology solutions has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 5.4% over the last 60 days.

Office Depot has a price-to-earnings ratio (P/E) of 5.90, compared with 8.10 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>